1997
DOI: 10.1006/taap.1996.8022
|View full text |Cite
|
Sign up to set email alerts
|

Antiestrogenic Activity of Hydroxylated Polychlorinated Biphenyl Congeners Identified in Human Serum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
75
1

Year Published

1997
1997
2012
2012

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 150 publications
(80 citation statements)
references
References 2 publications
4
75
1
Order By: Relevance
“…4-OH-CB107 is known to exert anti-estrogenicity in vitro (Moore et al, 1997;Meerts, unpublished results). High concentrations of this metabolite in the developing brain may influence CNS dopaminergic and serotonergic function, as there appear to exist interactive relationships between estrogens and DA as well as between estrogens and 5-HT (Rubinow et al, 1998;reviewed in McEwen and Alves, 1999).…”
Section: Discussionmentioning
confidence: 96%
“…4-OH-CB107 is known to exert anti-estrogenicity in vitro (Moore et al, 1997;Meerts, unpublished results). High concentrations of this metabolite in the developing brain may influence CNS dopaminergic and serotonergic function, as there appear to exist interactive relationships between estrogens and DA as well as between estrogens and 5-HT (Rubinow et al, 1998;reviewed in McEwen and Alves, 1999).…”
Section: Discussionmentioning
confidence: 96%
“…A number of OHPCBs identified in human serum exhibited antiestrogenic activity in the rat uterine estrogen-binding assay and in the MCF-7 cell proliferation assay (9). OH-PCBs bound to the estrogen receptor and transactivated the estrogen receptor to DNA binding and altered gene expression in in vitro reporter gene assays (9,10 (17). PCB mixtures are also capable of inducing T4 glucuronidation (18)(19)(20)(21).…”
Section: Estrogen Receptor-mediated Effectsmentioning
confidence: 99%
“…To demonstrate a specific interaction between chemicals and ER, an assay with a chimeric receptor molecule has been developed 42,[45][46][47] , in which the C-terminal liganddependent activation domain of ER is fused to the DNA binding domain of yeast transcription factor GAL4. This artificial chimeric receptor molecule retains the ligandspecificity, and it can give rise to transactivation via the GAL4 binding sequence located upstream of the reporter gene.…”
Section: Other Applicationsmentioning
confidence: 99%